FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Teva Pharmaceuticals Testosterone Gel 1% Recall

Testosterone Gel 1%, 2

Teva Pharmaceuticals USA · Parsippany, NJ

Risk level
Class III
Reported by FDA
Nov 25, 2020
Recall ID
D-0100-2021
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Testosterone Gel 1% starting Nov 11, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0100-2021 on Nov 25, 2020. Reason: Superpotent Drug: High out-of-specification assay results were obtained during stability testing. Status: Terminated.

Why it was recalled

Superpotent Drug: High out-of-specification assay results were obtained during stability testing.

Product description

Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.

Lot numbers, UPCs & expiration codes

Lot Number: 1351104, Exp 08/2021

Where it was sold

Product was distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0100-2021
Classification
Class III
Status
Terminated
Recall initiated
Nov 11, 2020
FDA report date
Nov 25, 2020
Quantity
12,088 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0100-2021, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
86738
Address
400 Interpace Pkwy
Code information
Lot Number: 1351104, Exp 08/2021
Postal code
07054-1120
Report date
Nov 25, 2020
Product type
Drugs
Recall number
D-0100-2021
Classification
Class III
Recalling firm
Teva Pharmaceuticals USA
Product quantity
12,088 cartons
Termination date
Jun 24, 2021
Reason for recall
Superpotent Drug: High out-of-specification assay results were obtained during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.
Distribution pattern
Product was distributed Nationwide in the USA.
Recall initiation date
Nov 11, 2020
Initial firm notification
Letter
Center classification date
Nov 20, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0100-2021, published Nov 25, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls